Picture of Avrobio logo

AVRO Avrobio Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Avrobio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-46.4-73-120-119-106
Depreciation
Non-Cash Items4.156.6315.518.414.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital4.18-2.184.241.3-7.4
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-37.6-67.7-98.8-98-97.2
Capital Expenditures-1.83-1.58-1.18-2.46-0.267
Purchase of Fixed Assets
Cash from Investing Activities-1.83-1.58-1.18-2.46-0.267
Financing Cash Flow Items-20-0.3080
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities16013017330.40.262
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash12160.772.6-70.1-97.2